http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10398674-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d4c44fc5d809eefbe7e86f7e8c6d4ff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-32 |
| filingDate | 2015-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69f8a90cb8250df82383eed8b518b1f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3edd6d6ad2c3fb8a0cbb57ddb8019e2b |
| publicationDate | 2019-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-10398674-B2 |
| titleOfInvention | Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancers |
| abstract | An embodiment of the invention provides a cannabis-based flavonoid pharmaceutical composition including any one or more selected, from among the group of Apigenin, Cannflavin. A. Cannflavin B, Cannflavin C, Chrysoeriol, Cosmosiin, Flavocannabiside, Kaempferol, Luteolin, Myricetin, Orientin, Isoorientin (Homoorientin), Quercetin (+)-Taxifolin, Vitexin, and Isovitexin, or their synthases, for the prevention and treatment of certain cancers that can be treated by therapeutically targeting oncogenic factors including kinases, sirtuins, bromodomains, matrix metalloproteinases and BCL-2. Some of the cancers that can be treated by use of cannabis flavonoids based on the inhibition of these therapeutic targets include brain, breast, colon, renal, liver, lung, pancreatic, prostate, leukemia, melanoma as well as any other cancers that overexpress the oncogenic factors inhibited by the cannabis flavonoids identified herein. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10632098-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019262305-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11141401-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021053513-A1 |
| priorityDate | 2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.